Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefanis

Showing results (81-90 of 859) with videos related to

Pageof 86
Sort By:
Psychiatrike = Psychiatriki|June 17, 2020
[Childhood adverse traumatic experiences and schizophrenia]I Kosteletos, K Kollias, N Stefanis
Revue Neurologique|August 1, 1972
[Psychotropic drugs and neurotransmitter substances]A G Maillis, C N Stefanis
Social Psychiatry and Psychiatric Epidemiology|October 1, 1992
Changes in the prevalence of symptoms of depression and depression across GreeceM G Madianos, C N Stefanis
Science (New York, N.Y.)|March 26, 1976
Marihuana effectsC N Stefanis, M R Issidorides
Biological Psychiatry|February 1, 1976
Histochemical changes in the blood cells of schizophrenic patients under pimozide treatmentC N Stefanis, M R Issidorides
Minerva Medica|April 25, 1970
[Our experience with Vinca alkaloids in the poly-chemotherapy of inoperable bronchopulmonary cancer]R Mariani, M Bo de Stefanis
Journal of Parkinson'S Disease|July 1, 2025
Gaps in the Parkinson's disease therapeutic clinical pipeline: A focus on approaches targeting disease pathobiologyChristos Koros, Brian Fiske, Leonidas Stefanis
Advances in Clinical Chemistry|November 25, 2022
Stress system and related biomarkers in Parkinson's diseaseAnastasia Bougea, Leonidas Stefanis, George Chrousos
Journal of Neural Transmission (Vienna, Austria : 1996)|August 12, 2019
Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic reviewAnastasia Bougea, Christos Koros, Leonidas Stefanis
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 2, 2008
Severe dysphagia as the presenting symptom of Wernicke-Korsakoff syndrome in a non-alcoholic manIlias Karaiskos, Ioannis Katsarolis, Leonidas Stefanis
Pageof 86

Showing results (81-90 of 859) with videos related to

Sort By:
Pageof 86
Psychiatrike = Psychiatriki|June 17, 2020
[Childhood adverse traumatic experiences and schizophrenia]I Kosteletos, K Kollias, N Stefanis
Revue Neurologique|August 1, 1972
[Psychotropic drugs and neurotransmitter substances]A G Maillis, C N Stefanis
Social Psychiatry and Psychiatric Epidemiology|October 1, 1992
Changes in the prevalence of symptoms of depression and depression across GreeceM G Madianos, C N Stefanis
Science (New York, N.Y.)|March 26, 1976
Marihuana effectsC N Stefanis, M R Issidorides
Biological Psychiatry|February 1, 1976
Histochemical changes in the blood cells of schizophrenic patients under pimozide treatmentC N Stefanis, M R Issidorides
Minerva Medica|April 25, 1970
[Our experience with Vinca alkaloids in the poly-chemotherapy of inoperable bronchopulmonary cancer]R Mariani, M Bo de Stefanis
Journal of Parkinson'S Disease|July 1, 2025
Gaps in the Parkinson's disease therapeutic clinical pipeline: A focus on approaches targeting disease pathobiologyChristos Koros, Brian Fiske, Leonidas Stefanis
Advances in Clinical Chemistry|November 25, 2022
Stress system and related biomarkers in Parkinson's diseaseAnastasia Bougea, Leonidas Stefanis, George Chrousos
Journal of Neural Transmission (Vienna, Austria : 1996)|August 12, 2019
Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic reviewAnastasia Bougea, Christos Koros, Leonidas Stefanis
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 2, 2008
Severe dysphagia as the presenting symptom of Wernicke-Korsakoff syndrome in a non-alcoholic manIlias Karaiskos, Ioannis Katsarolis, Leonidas Stefanis
Pageof 86